Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

SSRIs increase risk of blood transfusion in patients admitted for hip surgery.

Schutte HJ, Jansen S, Schafroth MU, Goslings JC, van der Velde N, de Rooij SE.

PLoS One. 2014 May 21;9(5):e95906. doi: 10.1371/journal.pone.0095906. eCollection 2014.

2.

Use of serotonergic antidepressants and bleeding risk in orthopedic patients.

van Haelst IM, Egberts TC, Doodeman HJ, Traast HS, Burger BJ, Kalkman CJ, van Klei WA.

Anesthesiology. 2010 Mar;112(3):631-6. doi: 10.1097/ALN.0b013e3181cf8fdf.

PMID:
20179499
3.

Selective serotonin reuptake inhibitors and intraoperative blood pressure.

van Haelst IM, van Klei WA, Doodeman HJ, Kalkman CJ, Egberts TC.

Am J Hypertens. 2012 Feb;25(2):223-8. doi: 10.1038/ajh.2011.194. Epub 2011 Oct 20.

PMID:
22012207
4.

Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.

Xiong GL, Jiang W, Clare RM, Shaw LK, Smith PK, O'Connor CM, Ranga K, Krishnan R, Kristin Newby L.

Clin Cardiol. 2010 Jun;33(6):E94-8. doi: 10.1002/clc.20621.

5.

Risk of perioperative blood transfusions and postoperative complications associated with serotonergic antidepressants in older adults undergoing hip fracture surgery.

Seitz DP, Bell CM, Gill SS, Reimer CL, Herrmann N, Anderson GM, Newman A, Rochon PA.

J Clin Psychopharmacol. 2013 Dec;33(6):790-8. doi: 10.1097/JCP.0b013e3182a58dce.

PMID:
24091859
6.

Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery.

Andreasen JJ, Riis A, Hjortdal VE, Jørgensen J, Sørensen HT, Johnsen SP.

Am J Cardiovasc Drugs. 2006;6(4):243-50.

PMID:
16913825
7.

Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty.

Gylvin SH, Jørgensen CC, Fink-Jensen A, Johansson PI, Kehlet H; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group.

Transfusion. 2017 Apr;57(4):971-976. doi: 10.1111/trf.13992. Epub 2017 Jan 31.

PMID:
28145024
8.

Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

Gärtner R, Cronin-Fenton D, Hundborg HH, Pedersen L, Lash TL, Sørensen HT, Kroman N.

BMC Surg. 2010 Jan 24;10:3. doi: 10.1186/1471-2482-10-3.

9.

Serotonin reuptake inhibitors and bleeding risks in major orthopedic procedures.

Tavakoli HR, DeMaio M, Wingert NC, Rieg TS, Cohn JA, Balmer RP, Dillard MA.

Psychosomatics. 2012 Nov-Dec;53(6):559-65. doi: 10.1016/j.psym.2012.05.001.

PMID:
23157994
10.

Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.

Basile FV, Basile AR, Basile VV.

Aesthetic Plast Surg. 2013 Jun;37(3):561-6. doi: 10.1007/s00266-013-0111-7. Epub 2013 Apr 10.

PMID:
23571783
11.

[Transfusion needs during intraoperative and immediate postoperative periods in arthroplasty of the hip and knee].

Rama-Maceiras P, Acción-Barral M, González-Vázquez M, Fernández-Rosado B, Diéguez-Fernández M, López-Vila I.

Rev Esp Anestesiol Reanim. 1999 Dec;46(10):445-52. Spanish.

PMID:
10670266
12.

Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.

Lindqvist PG, Nasiell J, Gustafsson LL, Nordstrom L.

J Thromb Haemost. 2014 Dec;12(12):1986-92. doi: 10.1111/jth.12757. Epub 2014 Nov 14.

13.

Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.

Auerbach AD, Vittinghoff E, Maselli J, Pekow PS, Young JQ, Lindenauer PK.

JAMA Intern Med. 2013 Jun 24;173(12):1075-81. doi: 10.1001/jamainternmed.2013.714.

14.

Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.

Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J.

Am J Gastroenterol. 2009 Jun;104(6):1475-82. doi: 10.1038/ajg.2009.128. Epub 2009 Apr 28.

PMID:
19491861
15.

Antidepressants and bleeding risk after face-lift surgery.

Harirchian S, Zoumalan RA, Rosenberg DB.

Arch Facial Plast Surg. 2012 Jul-Aug;14(4):248-52. doi: 10.1001/archfacial.2012.2.

PMID:
22801798
16.

Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study.

Wu X, Al-Abedalla K, Rastikerdar E, Abi Nader S, Daniel NG, Nicolau B, Tamimi F.

J Dent Res. 2014 Nov;93(11):1054-61. doi: 10.1177/0022034514549378. Epub 2014 Sep 3.

17.

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.

Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE.

Arch Intern Med. 2007 Jun 25;167(12):1240-5.

PMID:
17592096
18.

Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.

Tully PJ, Cardinal T, Bennetts JS, Baker RA.

Heart Lung Circ. 2012 Apr;21(4):206-14. doi: 10.1016/j.hlc.2011.12.002. Epub 2012 Jan 28.

PMID:
22285303
19.

New-onset hyponatraemia after surgery for traumatic hip fracture.

Rudge JE, Kim D.

Age Ageing. 2014 Nov;43(6):821-6. doi: 10.1093/ageing/afu069. Epub 2014 Jun 7.

PMID:
24908106
20.

Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.

Nørgaard M, Jacobsen J, Gasse C, Pedersen L, Mortensen PB, Sørensen HT.

J Clin Psychopharmacol. 2007 Jun;27(3):259-62.

PMID:
17502772

Supplemental Content

Support Center